|
HLB: |
Mutant trait: |
Mapping strain: |
Mapped to Chr: |
(Mb)----------(Cm) |
Notes: |
|---|---|---|---|---|---|
|
Leukocytosis |
C3H |
12 |
44-69 (22-29) | . | |
|
Neutrophilia |
129 |
17 |
23-30 (32-35) | . | |
|
Thrombocytopenia |
C3H |
4 |
117.9 (56.5) | = Mpl (thrombopoetin receptor) | |
|
Leukopenia |
C3H |
3 |
7.5 (6.6) | = IL-7 (interleukin 7) | |
|
Thrombocytopenia |
C3H |
8 |
2-39 (4-25) | . | |
|
Leukocytosis |
C3H |
17 |
34.8 (19.9) | = Lta (lymhotoxin A) | |
|
Leukopenia |
C3H |
10 |
82-90 (42-48) | ||
|
High cholesterol |
DBA2/J |
9 |
21.6 (5) | = LDLR | |
|
Low HDL |
129 |
10 |
25-82 (19-44) | . | |
|
Low HDL |
129 |
1 |
150-185 | . | |
|
Hyperglycemia |
BALB/cJ |
11 |
0-17 (0-4) | Locus includes Glucokinase (Gck) | |
|
Low fibrinogen |
C3H |
3 |
60-83 (26-48) | Locus includes Fga, Fgb, Fgg peptides | |
|
Obese (ES/EMS/f) |
BALB/cJ |
QTL |
No single locus | Ethane-Methyl-Sulphonate (EMS) treated hybrid ES cells (B6/129); Female used for mapping | |
|
Tachycardia |
BALB/cJ |
9 |
63-68 (30-35) | . |
